Buscar
28/08/2023
Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.
Marais LC, Nieuwoudt L, Nansook A, Menon A, Benito N. Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.. Journal Of Bone And Joint Infection. 2023; 8(4)DOI:10.5194/jbji-8-189-2023. PMID:37780528. IF:(Q/D).
01/01/2023
Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.
Espíndola R, Vella V, Benito N, Mur I, Tedeschi S, Zamparini E, Hendriks JGE, Sorlí L, Murillo O, Soldevila L, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, McNamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Dolores Del Toro M. Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.. JOURNAL OF HOSPITAL INFECTION. 2023; 142DOI:10.1016/j.jhin.2023.09.012. PMID:37797656. IF:3.900(Q1/2D).
01/01/2023
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
Grillo S, Pujol M, Miró JM, López-Contreras J, Euba G, Gasch O, Boix-Palop L, Garcia-País MJ, Pérez-Rodríguez MT, Gomez-Zorrilla S, Oriol I, López-Cortés LE, Pedro-Botet ML, San-Juan R, Aguado JM, Gioia F, Iftimie S, Morata L, Jover-Sáenz A, García-Pardo G, Loeches B, Izquierdo-Cárdenas Á, Goikoetxea AJ, Gomila-Grange A, Dietl B, Berbel D, Videla S, Hereu P, Padullés A, Pallarès N, Tebé C, Cuervo G, Carratalà J. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.. NATURE MEDICINE. 2023; 29(10)DOI:10.1038/s41591-023-02569-0. PMID:37783969. IF:58.700(Q1/1D).
01/11/2021
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study
Goffin, E, Candellier, A, Vart, P, Noordzij, M, Arnol, M, Covic, A, Lentini, P, Malik, S, Reichert, LJ, Sever, MS, Watschinger, B, Jager, KJ, Gansevoort, RT, Canal C., Facundo C., ERACODA Collaborators. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021; 36(11)DOI:10.1093/ndt/gfab200. PMID:34132811. IF:7.186(Q1/2D).
10/02/2026
A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin
Rovira, I, Montemayor, E, Gil-Alonso, S, Miranda-Cadena, K, Sanchez-Reus, F, Quindos, G, Eraso, E, Jauregizar, N. A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin. ACS Omega. 2026; 11(5)DOI:10.1021/acsomega.5c10111. PMID:41696345. IF:4.300(Q2/4D).
01/02/2026
Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study
Pérez, MAC, Grillo, S, Rombauts, A, Martinez, MAR, Falcó-Roget, A, Albasanz-Puig, A, Viñado-Pérez, B, Fernández-Hidalgo, N, Camps-Relats, L, Bergas, A, Laporte-Amargos, J, López-Contreras, J, Escolà-Vergé, L. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2026; 67(2)DOI:10.1016/j.ijantimicag.2025.107706. PMID:41456670. IF:4.600(Q1/2D).